DE SERVI, STEFANO
 Distribuzione geografica
Continente #
NA - Nord America 3.276
AS - Asia 1.965
EU - Europa 1.884
SA - Sud America 194
AF - Africa 57
Totale 7.376
Nazione #
US - Stati Uniti d'America 3.217
CN - Cina 942
SG - Singapore 427
IE - Irlanda 375
DE - Germania 236
SE - Svezia 235
UA - Ucraina 228
HK - Hong Kong 218
FI - Finlandia 196
RU - Federazione Russa 179
VN - Vietnam 158
GB - Regno Unito 138
BR - Brasile 136
FR - Francia 99
IT - Italia 90
BD - Bangladesh 46
IN - India 42
AT - Austria 30
CA - Canada 28
ZA - Sudafrica 26
MX - Messico 23
AR - Argentina 21
JP - Giappone 20
IQ - Iraq 17
PL - Polonia 16
NL - Olanda 14
VE - Venezuela 14
TR - Turchia 11
BE - Belgio 10
ES - Italia 10
LT - Lituania 9
ID - Indonesia 8
PH - Filippine 8
CO - Colombia 7
EC - Ecuador 7
KR - Corea 7
SA - Arabia Saudita 7
UZ - Uzbekistan 7
MA - Marocco 6
PK - Pakistan 6
AE - Emirati Arabi Uniti 5
CZ - Repubblica Ceca 5
JO - Giordania 5
MU - Mauritius 5
OM - Oman 5
AZ - Azerbaigian 4
DZ - Algeria 4
EG - Egitto 4
IR - Iran 4
KE - Kenya 4
PY - Paraguay 4
TN - Tunisia 4
JM - Giamaica 3
LV - Lettonia 3
NP - Nepal 3
PE - Perù 3
PT - Portogallo 3
CH - Svizzera 2
CY - Cipro 2
IL - Israele 2
MY - Malesia 2
TH - Thailandia 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BG - Bulgaria 1
BH - Bahrain 1
CL - Cile 1
CR - Costa Rica 1
DK - Danimarca 1
ET - Etiopia 1
GY - Guiana 1
HN - Honduras 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MT - Malta 1
NI - Nicaragua 1
PA - Panama 1
PS - Palestinian Territory 1
QA - Qatar 1
SI - Slovenia 1
TT - Trinidad e Tobago 1
UG - Uganda 1
Totale 7.376
Città #
Chandler 441
Dublin 375
Ashburn 329
San Jose 299
Jacksonville 249
Hong Kong 215
Singapore 201
Dallas 177
Nanjing 175
Beijing 170
Boardman 118
Wilmington 107
Council Bluffs 97
New York 94
Ann Arbor 89
Los Angeles 83
Helsinki 76
Princeton 75
Nanchang 73
Lawrence 70
Medford 65
Shenyang 64
Lauterbourg 63
Munich 63
Ho Chi Minh City 61
Hebei 54
Changsha 46
Jiaxing 44
Moscow 42
Houston 39
Hanoi 38
Hangzhou 37
Nuremberg 36
Tianjin 36
Woodbridge 34
Dearborn 31
Buffalo 26
Milan 25
Shanghai 25
Orem 24
Redondo Beach 23
Johannesburg 21
Tokyo 19
Verona 18
Fairfield 17
Santa Clara 17
Warsaw 16
Turku 15
Chennai 14
Denver 14
Mexico City 14
Montreal 13
Norwalk 13
Pavia 13
Chicago 11
Stockholm 11
Brussels 10
Phoenix 10
Brooklyn 9
Des Moines 9
Frankfurt am Main 9
London 9
Rio de Janeiro 9
San Francisco 9
Seattle 9
Vienna 9
Jinan 8
São Paulo 8
Toronto 8
Guangzhou 7
Ankara 6
Atlanta 6
Boston 6
Da Nang 6
Falkenstein 6
Philadelphia 6
Tashkent 6
Amman 5
Amsterdam 5
Baghdad 5
Guarulhos 5
Haiphong 5
Hefei 5
Mumbai 5
Portsmouth 5
Taizhou 5
The Dalles 5
Baku 4
Berlin 4
Biên Hòa 4
Borås 4
Bắc Ninh 4
Columbus 4
Miami 4
Muscat 4
Ningbo 4
Poplar 4
Redwood City 4
Riyadh 4
Sorocaba 4
Totale 4.882
Nome #
Causes and clinical implications of premature discontinuation of dual antiplatelet therapy. 148
Clinical impact of persistent left bundle-branch block after transcatheter aortic valve implantation with CoreValve revalving system 139
Bridge with intravenous antiplatelet therapy during temporary withdrawal of oral agents for surgical procedures: a systematic review. 139
Clinical outcomes for prasugrel versus clopidogrel in patients with unstable angina or non-ST-elevation myocardial infarction: an analysis from the TRITON-TIMI 38 trial. 136
Clinical Impact of Persistent Left Bundle-Branch Block After Transcatheter Aortic Valve Implantation With CoreValve Revalving System. 135
Comparison of Outcomes of Staged Complete Revascularization Versus Culprit Lesion–Only Revascularization for ST-Elevation Myocardial Infarction and Multivessel Coronary Artery Disease 133
CoreValve implantation for severe aortic regurgitation: a multicentre registry. 131
Comparison of coronary lesions obtained by directional coronary atherectomy in unstable angina, stable angina, and restenosis after either atherectomy or angioplasty. 131
Patient Outcomes With STEMI Caused by Aneurysmal Coronary Artery Disease and Treated With Primary PCI 128
Clinical governance programme in patients with acute coronary syndrome: Design and methodology of a quality improvement initiative 128
Absence of correlation between coronary thrombosis and postatherectomy restenosis 127
Increased concentrations of inflammatory mediators in unstable angina: correlation with serum troponin T 126
Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial 126
Continuous venovenous hemofiltration after coronary procedures for the prevention of contrast-induced acute kidney injury in patients with severe chronic renal failure 125
Anemia in octogenarians with non-ST elevation acute coronary syndrome: aging or disease? 123
Clinical impact of simultaneous complete revascularization vs. culprit only primary angioplasty in patients with st-elevation myocardial infarction and multivessel disease: a meta-analysis. 123
Causes of death in patients ≥75 years of age with non-ST-segment elevation acute coronary syndrome. 122
Elevated serum uric acid affects myocardial reperfusion and infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention 121
Antithrombotic strategies in the catheterization laboratory for patients with acute coronary syndromes undergoing percutaneous coronary interventions: Insights from the EmploYEd antithrombotic therapies in patients with acute coronary Syndromes HOspitalized in Italian cardiac care units Registry 121
Appraising the impact of left ventricular ejection fraction on outcomes of percutaneous drug-eluting stenting for unprotected left main disease: insights from a multicenter registry of 975 patients. 120
Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management: AKI-MATRIX 116
Early Aggressive Versus Initially Conservative Treatment in Elderly Patients With Non–ST-Segment Elevation Acute Coronary Syndrome A Randomized Controlled Trial 116
Meta-Analysis of Impact of Different Types and Doses of Statins on New-Onset Diabetes Mellitus. 115
Favorable effect of glycoprotein IIbIIIa inhibitors among STEMI patients treated with primary PCI and incomplete ST resolution 114
One-year mortality in elderly adults with non-ST-elevation acute coronary syndrome: effect of diabetic status and admission hyperglycemia. 113
Prognostic Impact of in-Hospital-Bleeding in Patients With ST-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention 112
Impact of Gene Polymorphisms, Platelet Reactivity, and the SYNTAX Score on 1-Year Clinical Outcomes in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: The GEPRESS Study. 111
APpropriAteness of percutaneous Coronary interventions in patients with ischaemic HEart disease in Italy: The APACHE pilot study 110
Risk of stroke with percutaneous coronary intervention compared with on-pump and off-pump coronary artery bypass graft surgery: Evidence from a comprehensive network meta-analysis. 109
Detection of tissue factor antigen and coagulation activity in coronary artery thrombi isolated from patients with ST-segment elevation acute myocardial infarction. 108
Ischaemic and bleeding complications with new, compared to standard, ADP-antagonist regimens in acute coronary syndromes: a meta-analysis of randomized trials. 107
Low-molecular-weight heparins vs. unfractionated heparin in the setting of percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis. 105
Does the target vessel impact on results of percutaneous coronary intervention for bifurcation lesions? Insights from the I-BIGIS registry. 105
Dual versus triple therapy in patients on oral anticoagulants and undergoing coronary stent implantation: A systematic review and meta-analysis 104
Importance and limits of pre-hospital electrocardiogram in patients with ST elevation myocardial infarction undergoing percutaneous coronary angioplasty. 103
Treating acute coronary syndromes with new antiplatelet drugs: the mortality issue with prasugrel and ticagrelor. 103
Quality and appropriateness of coronary angioplasty in Lombardy: analysis of data from the registry of the Italian Society of Invasive Cardiology (SICI-GISE)]. 102
Management of patients with recently implanted coronary stents on dual antiplatelet therapy who need to undergo major surgery. 102
Contemporary antithrombotic strategies in patients with acute coronary syndrome admitted to cardiac care units in Italy: The EYESHOT Study 102
Impact of drug-eluting stents and diabetes mellitus in patients with coronary bifurcation lesions: a survey from the Italian Society of Invasive Cardiology. 99
Risk of stroke with coronary artery bypass graft surgery compared with percutaneous coronary intervention 99
Leptin affects the inflammatory response after STEMI 99
Impact of primary PCI volume on hospital mortality in STEMI patients: does time-to-presentation matter? 97
Drug-eluting stents vs. bare metal stents in saphenous vein graft disease. Insights from a meta-analysis of 7,090 patients. 97
Time course changes of cystatin C and inflammatory and biochemical markers in non-ST-elevation acute coronary syndromes. 93
Has hyperglycemia a different prognostic role in STEMI patients with or without diabetes? 92
How to reduce mortality in ST-elevation myocardial infarction patients treated with primary percutaneous coronary interventions: cut the bleeding. 91
Trilogy: In search of the lost ring. 91
Is intravascular ultrasound beneficial for percutaneous coronary intervention of bifurcation lesions? Evidence from a 4,314-patient registry. 91
Safety and efficacy of biodegradable vs. durable polymer drug-eluting stents: evidence from a meta-analysis of randomised trials. 90
Simplifying clinical risk prediction for percutaneous coronary intervention of bifurcation lesions: the case for the ACEF (age, creatinine, ejection fraction) score. 89
Plasma levels of interleukin 2, 6, 10 and phenotypic characterization of circulating T lymphocytes in ischemic heart disease 89
Association of statin pretreatment with presentation characteristics, infarct size and outcome in older patients with acute coronary syndrome: the Elderly ACS-2 trial 88
Lack of implementation of guidelines recommendations for coronary revascularization in stable patients with complex disease is associated with high rates of incomplete revascularization : Analysis from the Apache study. 88
Heart rate at discharge and long-term prognosis following percutaneous coronary intervention in stable and acute coronary syndromes - results from the BASKET PROVE trial. 87
Histopathologic features in atherectomy samples obtained from patient with unstable angina, stable angina and restenosis. Directional Atherectomy Lombardi Group 86
Early and long-term outlook of percutaneous coronary intervention for bifurcation lesions in young patients. 86
The bivalirudin paradox: high evidence, low use. 85
LombardIMA: a regional registry for coronary angioplasty in ST-elevation myocardial infarction. 85
Defining high-risk patients with ST-segment elevation acute myocardial infarction undergoing primary percutaneous coronary intervention: A comparison among different scoring systems and clinical definitions. 85
To kiss or not to kiss? Impact of final kissing-balloon inflation on early and long-term results of percutaneous coronary intervention for bifurcation lesions. 83
Interplay between Mitral Regurgitation and Transcatheter Aortic Valve Replacement with the CoreValve Revalving System: A Multicenter Registry. 83
Renal function estimation and one-year mortality in elderly patients with non-ST-segment elevation acute coronary syndromes. 75
Derivation and validation of the incomplete ST-segment resolution score and its usefulness for treatment with glycoprotein IIb-IIIa inhibitors 74
Beneficial Effects of IABP in Anterior Myocardial Infarction Complicated by Cardiogenic Shock 74
Early vs. delayed invasive strategy in patients with acute coronary syndromes without ST-segment elevation: a meta-analysis of randomized studies. 69
Early invasive versus selectively invasive strategy in patients with non-ST-segment elevation acute coronary syndrome: impact of age. 67
Interplay between mitral regurgitation and transcatheter aortic valve replacement with the CoreValve Revalving System: a multicenter registry. 65
Long-term benefits and risks of drug-eluting compared to bare-metal stents in patients with versus without chronic kidney disease. 63
Perioperative management of antiplatelet therapy in patients with coronary stents undergoing cardiac and non-cardiac surgery: a consensus document from Italian cardiological, surgical and anaesthesiological societies. 62
How to explain the reduced cardiovascular mortality in the ticagrelor arm of the PLATO trial? 62
Neutrophil count as a risk factor for cardiovascular diseases: How can we manage it? 45
Percutaneous coronary interventions for stable ischemic heart disease in Italy 45
Is the use of risk scores an indicator of guideline adherence for patients with acute coronary syndromes? Insights from the EYESHOT registry 35
Prasugrel and ticagrelor compared to clopidogrel in non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary interventions: Certainties and uncertainties 32
Totale 7.480
Categoria #
all - tutte 29.546
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.546


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202135 0 0 0 0 0 0 0 0 0 0 0 35
2021/2022302 5 3 4 2 5 1 5 24 20 9 44 180
2022/20231.197 178 92 10 93 143 104 0 74 441 6 28 28
2023/2024338 34 79 9 15 28 111 2 22 2 20 9 7
2024/20251.006 24 83 24 18 22 41 42 88 238 28 134 264
2025/20262.463 215 182 247 258 261 110 447 104 186 207 193 53
Totale 7.480